Floxuridine
is a fluorinated pyrimidine monophosphate alternation of
5-fluoro-2'-deoxyuridine-5'-phosphate (FUDR-MP) with antineoplastic activity.
As an antimetabolite, floxuridine inhibits thymidylate synthase, consistent in
disruption of DNA amalgam and cytotoxicity. This abettor is aswell metabolized
to fluorouracil and added metabolites that can be congenital into RNA and
arrest the appliance of preformed uracil in RNA synthesis.
Floxuridine
aboriginal acquired FDA approval in December 1970 beneath the cast name FUDR.
The biologic was initially marketed by Roche, which aswell did a lot of the
antecedent plan on 5-fluorouracil. The National Cancer Institute was an
aboriginal developer of the drug. Roche awash its FUDR artefact band in 2001 to
F H Faulding, which became Mayne Pharma.